We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×

Home > News > Testing

MCR Labs Opens its First Facility Outside of Massachusetts

By Leo Bear-McGuinness

Published: Jan 28, 2021   

Complete the form below and we will email you a PDF version of "MCR Labs Opens its First Facility Outside of Massachusetts"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Analytical Cannabis?

Analytical Cannabis Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

MCR Labs Opens its First Facility Outside of Massachusetts

Image credit: MCR Labs

The analytical services of MCR Labs, one of Massachusetts’ larger cannabis testing companies, are now available in the state of Pennsylvania.

The new facility marks the company’s first expansion outside of Massachusetts.


Getting medical in Pennsylvania

As Pennsylvania does not legally permit recreational cannabis use, MCR’s new Allentown lab will only be testing medical marijuana samples.

“This is a huge step for us,” Michael Kahn, MCR’s president and founder, said in a statement. “We’re excited to be expanding and excited for the opportunity to carry out our mission of advancing public health and safety here in the Keystone State.”

Following its approval from the Pennsylvania Department of Health, MCR is the sixth medical cannabis testing lab in the state, joining the likes of Steep Hill Pennsylvania and Coral Reef Labs.

The facility is equipped to test samples for cannabinoids and terpenes, as well as impurities such as pesticides, residual solvents, heavy metals, microbes, mycotoxins, water activity, and moisture content.

Back in Massachusetts, MCR is one of three companies licensed to test medical marijuana, alongside ProVerde Laboratories and CDX Analytics.

Over the course of 2020, MCR reported a 38 percent increase in sample submissions. According to the company, 78 percent of these samples were from edibles and infused products, 28 percent were from cannabis flower, and 22 percent from vaporizer devices.

 

Like what you just read? You can find similar content on the topic tag shown below.

Testing

Stay connected with the latest news in cannabis extraction, science and testing

Get the latest news with the FREE weekly Analytical Cannabis newsletter

 
Advertisement